Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 See also  





2 References  














Template:Available forms of progesterone







Add links
 









Template
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Get shortened URL
Download QR code
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


  • t
  • e
  • Available forms of progesterone[sources 1][a]
    Route Form Dose Brand name Availability[b]
    Oral Capsule 100, 200, 300 mg Prometrium[c] Widespread
    Tablet (SR) 200, 300, 400 mg Dubagest SR[c] India
    Sublingual Tablet 10, 25, 50, 100 mg Luteina[c] Europe[d]
    Transdermal Gel[e] 1% (25 mg) Progestogel Europe
    Vaginal Capsule 100, 200 mg Utrogestan Widespread
    Tablet 100 mg Endometrin[c] Widespread
    Gel 4, 8% (45, 90 mg) Crinone[c] Widespread
    Suppository 200, 400 mg Cyclogest Europe
    Ring 10 mg/day[f] Fertiring[c] South America[g]
    Rectal Suppository 200, 400 mg Cyclogest Europe
    Uterine IUD 38 mg Progestasert Discontinued
    Intramuscular
    injection
    Oil solution 2, 5, 10, 20, 25,
    50, 100 mg/mL
    Proluton[c] Widespread
    Aq. susp. 12.5, 30, 100 mg/mL Agolutin[c] Europe[h]
    Emulsion 5, 10, 25 mg/mL Di-Pro-Emulsion Discontinued
    Microsph. 20, 100 mg/mL ProSphere[c] Mexico
    Subcutaneous Aq. soln. (inj.) 25 mg/vial Prolutex Europe
    Implant 50, 100 mg Proluton[c] Discontinued
    Intravenous Aq. soln. (inj.) 20 mg/mL Primolut Discontinued
    Sources and footnotes:
    1. ^ This table only includes products where progesterone is the sole active ingredient.
  • ^ See also: Progesterone (medication) § Availability
  • ^ a b c d e f g h i j Other brand names exist.
  • ^ Specifically in Poland and Ukraine.
  • ^ For local application to the breasts; negligible systemic effect.
  • ^ One progesterone vaginal ring provides 10mg of progesterone each day for 3 months.
  • ^ Specifically in Chile, Ecuador, and Peru.
  • ^ Specifically the Czech Republic and Slovakia.
  • Pharmacokinetics of progesterone § Routes of administration
  • Template:Available forms of estradiol
  • Template:Available forms of testosterone
  • References

    1. ^ "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 26 July 2018.
  • ^ Engel J, Kleemann A, Kutscher B, Reichert D (14 May 2014). Pharmaceutical Substances, 5th Edition, 2009: Syntheses, Patents and Applications of the most relevant APIs. Thieme. pp. 1145–. ISBN 978-3-13-179275-4.
  • ^ Becker KL (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 2168–. ISBN 978-0-7817-1750-2.
  • ^ Anita MV, Jain S, Goel N (31 July 2018). Use of Progestogens in Clinical Practice of Obstetrics and Gynecology. JP Medical Ltd. pp. 4–. ISBN 978-93-5270-218-3.
  • ^ Sauer MV (1 March 2013). Principles of Oocyte and Embryo Donation. Springer Science & Business Media. pp. 7, 117–118. ISBN 978-1-4471-2392-7.
  • ^ Elder K, Dale B (2 December 2010). In-Vitro Fertilization. Cambridge University Press. pp. 26–. ISBN 978-1-139-49285-0.
  • ^ "PROSPHERE CARNOT". Archived from the original on 2019-12-30.
  • ^ Heinrich Kahr (8 March 2013). Konservative Therapie der Frauenkrankheiten: Anzeigen, Grenzen und Methoden Einschliesslich der Rezeptur. Springer-Verlag. pp. 21–. ISBN 978-3-7091-5694-0.
  • ^ Basic Sex Hormone Therapy. Schering A.G. 1962. p. 96.
  • ^ Current Medicine and Drugs. 1962. p. 40. Primolut Intravenous (Schering A.G. Berlin)
  • ^ Haleem S, Khan MI (March 2015). "Changing Indian Market Trends of NMP: A Review" (PDF). International Journal of Pharma Research & Review. 4 (3): 28–30. ISSN 2278-6074. S2CID 74224514.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Template:Available_forms_of_progesterone&oldid=1196488820"

    Categories: 
    Medication templates
    Templates that generate named references
     



    This page was last edited on 17 January 2024, at 17:29 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki